Association of Recent and Long-Term Supplement Intakes With Laboratory Indices in Patients With COVID-19 in Tehran, Iran, During 2020

Abstract

BackgroundAlthough previous studies observed the relationship between individual dietary supplements and enhancing body resistance against viruses, few studies have been conducted regarding the role of different supplements in treatment of COVID-19. This article aims to determine the association of recent and long-term supplement consumption on the biochemical indices and impatient duration among patients with COVID-19. MethodsIn this cross-sectional study on 300 adult men and women with COVID-19, recent and long-term supplement intakes were investigated by using a questionnaire. In addition, lifestyle was also assessed in aspects of fruits and vegetable consumption, physical activity, sleeping duration, fluid intake, and smoking status. Furthermore, the laboratory and paraclinical parameters were obtained from medical records. The relationship between supplement intake with the length of hospitalization and clinical laboratory tests was investigated by one-way analysis of variance (ANOVA). ResultsThose patients with supplement intake in the last 2 months had a significantly lower amount of blood urea nitrogen (BUN) (31.31 +/- 13.87 vs. 37.57 +/- 19.77 mg/dL, P: 0.002) and higher serum 25(OH)D (28.13 +/- 14.09 vs. 23.81 +/- 13.55 ng/mL, P: 0.03). Subjects with long-term supplement intake had a significantly lower invasive oxygen support (0.00 vs 5.10 , P: 0.05), lactate dehydrogenase (LDH) (498.11 +/- 221.43 vs. 576.21 +/- 239.84 U/L, P: 0.02), fewer days of fever (0.49 +/- 3.54 vs. 2.64 +/- 9.21, P: 0.02), and higher serum 25(OH)D (31.03 +/- 13.20 vs. 22.29 +/- 13.42 ng/mL, P < 0.001). The length of hospital stay was practically the same between groups who received and did not receive supplementation during the 2 months prior to hospitalization (6.36 +/- 3.32 vs. 6.71 +/- 4.33 days, P: 0.004). Similarly, people who took supplements during the past year had practically similar hospitalization lengths (6.29 +/- 4.13 vs. 6.74 +/- 3.55 days, P: 0.004). ConclusionIn conclusion, although practically the length of hospital stay was the same in both groups of supplement consumers and others, immune-boosting supplements were associated with improved several laboratory indices. However, due to the cross-sectional nature of our study, further longitudinal studies seem to be essential.